News | October 13, 2022
Celanese support the sustained-release drug delivery market
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
Subscribe To Our Newsletter & Stay Updated
